Retinoblastoma is lethal by metastasis if left untreated, so the primary goal of therapy is to
preserve life, with ocular survival, visual preservation and quality of life as secondary aims …

The management of intraocular retinoblastoma is rapidly changing, and even recent reviews
on the subject are behind existing practices. The 4 authors of this report collectively …

Verteporfin (VP), a benzoporphyrin derivative, is clinically used in photodynamic therapy for
neovascular macular degeneration. Recent studies indicate that VP may inhibit growth of …

Progress has been made in the past few years in the management of retinoblastoma with
better enucleation implants, chemoreduction-prevention of pinealoblastoma and excellent …

Purpose To describe the ocular side effects in patients receiving intravitreal injection therapy
(IViT) for retinoblastoma. Methods PubMed (1946–present), Scopus (all years), Science …

Purpose The introduction of intra-arterial chemotherapy (IAC) as salvage treatment has
improved the prognosis for eye conservation in group D retinoblastoma. The aim of this …

Treatment of retinoblastoma has undergone significant advancements over the past few
decades, as globe-salvaging therapies with chemoreduction and focal consolidation are …

Focal therapy is emerging as an alternative to active surveillance for the management of low-
risk prostate cancer in carefully selected patients. The aim of focal therapy is long-term …

Retinoblastoma is the most common primary intraocular malignancy of childhood. A
potentially curable cancer, its treatment has improved significantly over the last few decades …

Progressive advances in the understanding of retinoblastoma pathogenesis continue to lead
treatment strategies. Improvements in the diagnosis and management of retinoblastoma are …